OBJECTIVE: To test the hypothesis that the lectin-like domain of tumor necrosis factor, mimicked by the TIP peptide, can improve lung function after unilateral orthotopic lung isotransplantation. Because of a lack of a specific treatment for ischemia reperfusion-mediated lung injury, accompanied by a disrupted barrier integrity and a dysfunctional alveolar liquid clearance, alternative therapies restoring these parameters after lung transplantation are required. DESIGN: Prospective, randomized laboratory investigation. SETTING: University-affiliated laboratory. SUBJECTS: Adult female rats. INTERVENTIONS: Tuberoinfundibular peptide, mimicking the lectin-like domain of tumor necrosis factor, mutant TIP peptide, N,N'-diacetylchitobiose/TIP peptide, and amiloride/TIP peptide were instilled intratracheally in the left lung immediately before the isotransplantation was performed. An additional group received an intravenous TIP peptide treatment, 1.5 mins before transplantation. Studies using isolated rat type II alveolar epithelial cell monolayers and ovine pulmonary endothelial cells were also performed. MEASUREMENTS AND MAIN RESULTS: Intratracheal pretreatment of the transplantable left lung with the TIP peptide, but not with an inactive mutant TIP peptide, resulted in significantly improved oxygenation 24 hrs after transplantation. This treatment led to a significantly reduced neutrophil content in the lavage fluid. Both the effects on oxygenation and neutrophil infiltration were inhibited by the epithelial sodium channel blocker amiloride. The TIP peptide blunted reactive oxygen species production in pulmonary artery endothelial cells under hypoxia and reoxygenation and reduced reactive oxygen species content in the transplanted rat lungs in vivo. Ussing chamber experiments using monolayers of primary type II rat pneumocytes indicated that the primary site of action of the peptide was on the apical side of these cells. CONCLUSIONS: These data demonstrate that the TIP peptide significantly improves lung function after lung transplantation in the rat, in part, by reducing neutrophil content and reactive oxygen species generation. These studies suggest that the TIP peptide is a potential therapeutic agent against the ischemia reperfusion injury associated with lung transplantation.
OBJECTIVE: To test the hypothesis that the lectin-like domain of tumor necrosis factor, mimicked by the TIP peptide, can improve lung function after unilateral orthotopic lung isotransplantation. Because of a lack of a specific treatment for ischemia reperfusion-mediated lung injury, accompanied by a disrupted barrier integrity and a dysfunctional alveolar liquid clearance, alternative therapies restoring these parameters after lung transplantation are required. DESIGN: Prospective, randomized laboratory investigation. SETTING: University-affiliated laboratory. SUBJECTS: Adult female rats. INTERVENTIONS: Tuberoinfundibular peptide, mimicking the lectin-like domain of tumor necrosis factor, mutant TIP peptide, N,N'-diacetylchitobiose/TIP peptide, and amiloride/TIP peptide were instilled intratracheally in the left lung immediately before the isotransplantation was performed. An additional group received an intravenous TIP peptide treatment, 1.5 mins before transplantation. Studies using isolated rat type II alveolar epithelial cell monolayers and ovine pulmonary endothelial cells were also performed. MEASUREMENTS AND MAIN RESULTS: Intratracheal pretreatment of the transplantable left lung with the TIP peptide, but not with an inactive mutant TIP peptide, resulted in significantly improved oxygenation 24 hrs after transplantation. This treatment led to a significantly reduced neutrophil content in the lavage fluid. Both the effects on oxygenation and neutrophil infiltration were inhibited by the epithelial sodium channel blocker amiloride. The TIP peptide blunted reactive oxygen species production in pulmonary artery endothelial cells under hypoxia and reoxygenation and reduced reactive oxygen species content in the transplanted rat lungs in vivo. Ussing chamber experiments using monolayers of primary type II rat pneumocytes indicated that the primary site of action of the peptide was on the apical side of these cells. CONCLUSIONS: These data demonstrate that the TIP peptide significantly improves lung function after lung transplantation in the rat, in part, by reducing neutrophil content and reactive oxygen species generation. These studies suggest that the TIP peptide is a potential therapeutic agent against the ischemia reperfusion injury associated with lung transplantation.
Authors: Tonghui Ma; Jay R Thiagarajah; Hong Yang; Nitin D Sonawane; Chiara Folli; Luis J V Galietta; A S Verkman Journal: J Clin Invest Date: 2002-12 Impact factor: 14.808
Authors: Xiao Su; Laurent Robriquet; Hans G Folkesson; Michael A Matthay Journal: Am J Physiol Lung Cell Mol Physiol Date: 2005-11-11 Impact factor: 5.464
Authors: R Lucas; I Garcia; Y R Donati; M Hribar; S J Mandriota; C Giroud; W A Buurman; L Fransen; P M Suter; G Nunez; M S Pepper; G E Grau Journal: Eur J Immunol Date: 1998-11 Impact factor: 5.532
Authors: C Hession; J M Decker; A P Sherblom; S Kumar; C C Yue; R J Mattaliano; R Tizard; E Kawashima; U Schmeissner; S Heletky Journal: Science Date: 1987-09-18 Impact factor: 47.728
Authors: J J Peschon; J L Slack; P Reddy; K L Stocking; S W Sunnarborg; D C Lee; W E Russell; B J Castner; R S Johnson; J N Fitzner; R W Boyce; N Nelson; C J Kozlosky; M F Wolfson; C T Rauch; D P Cerretti; R J Paxton; C J March; R A Black Journal: Science Date: 1998-11-13 Impact factor: 47.728
Authors: Parastoo Hazemi; Susan J Tzotzos; Bernhard Fischer; Gowri Shankar Bagavananthem Andavan; Hendrik Fischer; Helmut Pietschmann; Rudolf Lucas; Rosa Lemmens-Gruber Journal: J Med Chem Date: 2010-10-27 Impact factor: 7.446
Authors: István Czikora; Abdel Alli; Hui-Fang Bao; David Kaftan; Supriya Sridhar; Hans-Jürgen Apell; Boris Gorshkov; Richard White; Astrid Zimmermann; Albrecht Wendel; Meike Pauly-Evers; Jürg Hamacher; Irène Garcia-Gabay; Bernhard Fischer; Alexander Verin; Zsolt Bagi; Jean Francois Pittet; Waheed Shabbir; Rosa Lemmens-Gruber; Trinad Chakraborty; Ahmed Lazrak; Michael A Matthay; Douglas C Eaton; Rudolf Lucas Journal: Am J Respir Crit Care Med Date: 2014-09-01 Impact factor: 21.405
Authors: Waheed Shabbir; Parastoo Scherbaum-Hazemi; Susan Tzotzos; Bernhard Fischer; Hendrik Fischer; Helmut Pietschmann; Rudolf Lucas; Rosa Lemmens-Gruber Journal: Mol Pharmacol Date: 2013-09-27 Impact factor: 4.436
Authors: Susan Tzotzos; Bernhard Fischer; Hendrik Fischer; Helmut Pietschmann; Rudolf Lucas; Gilles Dupré; Rosa Lemmens-Gruber; Parastoo Hazemi; Victoria Prymaka; Waheed Shabbir Journal: Pulm Pharmacol Ther Date: 2013-01-09 Impact factor: 3.410
Authors: Richard Schwameis; Sandra Eder; Helmut Pietschmann; Bernhard Fischer; Hermann Mascher; Susan Tzotzos; Hendrik Fischer; Rudolf Lucas; Markus Zeitlinger; Robert Hermann Journal: J Clin Pharmacol Date: 2014-03 Impact factor: 3.126
Authors: Chenling Xiong; Guang Yang; Sanjiv Kumar; Saurabh Aggarwal; Martin Leustik; Connie Snead; Juerg Hamacher; Bernhard Fischer; Nagavedi S Umapathy; Hamid Hossain; Albrecht Wendel; John D Catravas; Alexander D Verin; David Fulton; Stephen M Black; Trinad Chakraborty; Rudolf Lucas Journal: Vascul Pharmacol Date: 2010-01-13 Impact factor: 5.773
Authors: Rudolf Lucas; Guang Yang; Boris A Gorshkov; Evgeny A Zemskov; Supriya Sridhar; Nagavedi S Umapathy; Agnieszka Jezierska-Drutel; Irina B Alieva; Martin Leustik; Hamid Hossain; Bernhard Fischer; John D Catravas; Alexander D Verin; Jean-François Pittet; Ruth B Caldwell; Timothy J Mitchell; Stephen D Cederbaum; David J Fulton; Michael A Matthay; Robert W Caldwell; Maritza J Romero; Trinad Chakraborty Journal: Am J Respir Cell Mol Biol Date: 2012-05-10 Impact factor: 6.914